The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2024

Filed:

Aug. 27, 2020
Applicant:

The Trustees of Boston College, Chestnut Hill, MA (US);

Inventor:

Jianmin Gao, Newton, MA (US);

Assignee:

The Trustees of Boston College, Chesnut Hill, MA;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C40B 40/02 (2006.01); A61K 38/00 (2006.01); C07K 14/47 (2006.01); C12N 7/00 (2006.01); C12N 15/10 (2006.01); C40B 30/00 (2006.01); C40B 30/04 (2006.01); C40B 40/00 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C40B 40/02 (2013.01); A61K 38/00 (2013.01); C07K 14/4723 (2013.01); C12N 7/00 (2013.01); C12N 15/1037 (2013.01); C40B 30/04 (2013.01); G01N 33/5008 (2013.01); C40B 30/00 (2013.01); C40B 40/00 (2013.01);
Abstract

Low molecular weight molecules able to penetrate cells and tissues and having high specificity and affinity for the surfaces of proteins. Methods of making same, pharmaceutical compositions comprising same, and methods of treating cancers, infectious diseases, and diseases and disorders associated with aberrant protein expression using same. A method for selecting a therapeutic peptide for binding to an isolated and/or purified protein of interest by screening a phage display library containing phage particles with phage display peptides which have at least one APBA modified cysteine residue. The APBA modified cysteine residues bind to surface lysine residues on the isolated and/or purified protein of interest by dynamic covalent conjugation to form iminoboronates.


Find Patent Forward Citations

Loading…